Back

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

29 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Outcomes in atrial fibrillation: room for improvement? Biomarkers ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Francisco Marin

Virgen de la Arrixaca University Hospital, Murcia (Spain)

5 More presentations in this session

Presentation thumbnail
Stroke and cardiovascular outcomes for patients with atrial fibrillation in the community - an opportunity for improvement?
Doctor K. Poppe (Auckland, NZ)
Abstract
Presentation thumbnail
Thoracoscopic left atrial appendectomy can prevent patients with atrial fibrillation from thromboembolism without anticoagulants
Doctor T. Inoue (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment.
Doctor M. Esteve Pastor (Murcia, ES)
Abstract Slides
Presentation thumbnail
Predictive value of the CHA2DS2-VASc score for cardiovascular death in comparison with stroke in patients with atrial fibrillation: The Fushimi AF Registry
Doctor Y. An (Kyoto, JP)
Abstract
Presentation thumbnail
Performance of the CHA2DS2-VASc score in patients with atrial fibrillation and recent cancer
Doctor M. D'Souza (Copenhagen, DK)
Abstract

Access the full session

Session thumbnail
Outcomes in atrial fibrillation: room for improvement?

The Event

Event poster

ESC Congress 2017

29 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources